The winding road of laboratory-developed test (LDT) regulations is likely to see another twist as the recent election of Donald Trump to a second US presidential term puts FDA’s final rule on the line ...
AUSTIN, Texas--(BUSINESS WIRE)--Many clinical laboratories are now under the gun to achieve Phase One compliance with the Food and Drug Administration’s (FDA) LDT rule before the May 2025 deadline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback